Company intelligence / Profile preview

Proventis

Ownership: Private
Employees: ~3
Development stage: Other

Overview

Proventis is an Israeli private medical device startup developing a minimally invasive, long-term, reversible contraceptive implant for men. The company is focused on male reproductive health and aims to provide a reliable alternative to condoms and vasectomy through an in-office procedure that blocks sperm flow and can later be deactivated to restore fertility. Publicly available descriptions position the company as an early-stage, venture-backed life science company rather than a therapeutics developer. Its lead and apparently sole disclosed program is a reversible occlusion device for male contraception.

Therapeutic areas: Men's Health
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

Arieli GroupNGT HealthCare II

Beyond the preview

Go deeper on Proventis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proventis.